Findings

What do systematic reviews say?

6 questions · 6 findings · 1 reviews · Acute Respiratory Infections

No studies found 0 · 0%GRADE not reported 1 · 16.7%Very low 0 · 0%Low 0 · 0%Moderate 4 · 66.7%High 1 · 16.7%

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Measles cases ‐ convalescent serum · susceptible people exposed to measles

Immunoglobulin probably leads to lower measles cases ‐ convalescent serum compared with no treatment (moderate certainty).

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
RR 0.21 [0.15, 0.29]
3 studies · 301 participants
Moderate

Measles cases ‐ adult serum · susceptible people exposed to measles

Immunoglobulin probably leads to lower measles cases ‐ adult serum compared with no treatment (moderate certainty).

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
RR 0.52 [0.45, 0.59]
2 studies · 586 participants
Moderate

Measles cases ‐ gamma globulin · susceptible people exposed to measles

Immunoglobulin probably leads to lower measles cases ‐ gamma globulin compared with no treatment (moderate certainty).

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
RR 0.17 [0.08, 0.36]
2 studies · 545 participants
Moderate

Mortality due to measles · susceptible people exposed to measles

Immunoglobulin leads to lower mortality due to measles compared with no treatment (high certainty).

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
RR 0.24 [0.13, 0.44]
3 studies · 893 participants
High

Complications due to measles · susceptible people exposed to measles

Immunoglobulin probably leads to lower complications due to measles compared with no treatment (moderate certainty).

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
RR 0.18 [0.05, 0.6]
3 studies · 832 participants
Moderate

Adverse events · susceptible people exposed to measles

1 finding from 1 review

Post‐exposure passive immunisation for preventing measles 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported